Suvanza Pharma, LLC (SUVZ)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 23, 2026
Suvanza Pharma, LLC Market Cap
Suvanza Pharma, LLC has a market cap or net worth of $2.24 thousand as of April 28, 2026.
Market Cap
2.24K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 10, 2010, Suvanza Pharma, LLC's market cap has increased from 1.12K to 2.24K, an increase of 99.91%. That is a compound annual growth rate of 4.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 2.24K | - |
| Sep 24, 2025 | 2.24K | - |
| Aug 5, 2025 | 2.24K | 99.91% |
| Sep 21, 2021 | 1.12K | -99.80% |
| May 4, 2021 | 559.85K | - |
| Mar 29, 2021 | Upgrade Pro | Upgrade Pro |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2021 | Upgrade Pro | Upgrade Pro |
| Mar 12, 2021 | Upgrade Pro | Upgrade Pro |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
| Feb 10, 2021 | Upgrade Pro | Upgrade Pro |
| Sep 15, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 23, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 1, 2018 | Upgrade Pro | Upgrade Pro |
| Feb 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 13, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaStat | 3.53K |
| Entia Biosciences | 3.41K |
| Innoveren Scientific | 3.20K |
| Hemagen Diagnostics | 3.10K |
| Comera Life Sciences Holdings | 3.07K |
| Anthera Pharmaceuticals | 2.62K |
| OncoVista Innovative Therapies | 2.36K |
| Evelo Biosciences | 1.90K |